Insiders · PACB

Peter Fromen

Officer at Pacific Biosciences Of California, Inc. (PACB)

Peter Fromen has filed 2 insider reports with the SEC since January 2022, as officer at Pacific Biosciences Of California, Inc. (PACB). Peter Fromen made no open-market purchases or sales in the last 12 months. The latest filing, on March 5, 2022, reports grant or award at Pacific Biosciences Of California, Inc. (PACB).

Filings
2
Companies
1
Bought on market
None
Sold on market
$282K

Companies where Peter Fromen is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Pacific Biosciences Of California, Inc. logo
PACB
Pacific Biosciences Of California, Inc.
Officer190,280$282K$1.63Mar 5, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Peter Fromen with

Other insiders at the same companies

Questions about Peter Fromen

What is Peter Fromen's role at Pacific Biosciences Of California, Inc.?
Peter Fromen reports to the SEC as officer at Pacific Biosciences Of California, Inc. (PACB), according to the latest filing on March 5, 2022.
How many shares does Peter Fromen own?
After the latest filing that states it, Peter Fromen directly owned 190,280 shares of Pacific Biosciences Of California, Inc. (PACB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Fromen bought or sold stock recently?
The most recent open-market sale was on January 11, 2022: sold 19,720 shares of Pacific Biosciences Of California, Inc. (PACB) for $282K at an average of $14.30.
How do I get alerts when Peter Fromen files?
Follow Peter Fromen on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Peter Fromen (SEC CIK 0001838928). Totals count each trade once, skipping amendments whose original is on file, from Jan 13, 2022 on. View on SEC EDGAR · Get this as JSON